Association of depth of response with survival outcomes in prognostic groups of patients treated with cobimetinib (C) +/- vemurafenib (V): A pooled analysis of the BRIM-2,-3,-7, and coBRIM studies

Lewis, KD; Larkin, J; Ribas, A; Flaherty, KT; McArthur, GA; Ascierto, PA; Dreno, B; McKenna, E; Zhu, Q; Mun, Y; Hauschild, A

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017; 31 ( ): 47